Tel.: +972-3-6407305 or +972-3-6409109; Fax: +972-3-6409109.
No evidence supports vitamin E indiscriminate supplementation
Article first published online: 28 OCT 2009
Copyright © 2009 International Union of Biochemistry and Molecular Biology, Inc.
Volume 35, Issue 6, pages 469–473, November/December 2009
How to Cite
Dotan, Y., Lichtenberg, D. and Pinchuk, I. (2009), No evidence supports vitamin E indiscriminate supplementation. BioFactors, 35: 469–473. doi: 10.1002/biof.61
- Issue published online: 27 NOV 2009
- Article first published online: 28 OCT 2009
- Manuscript Accepted: 15 SEP 2009
- Manuscript Received: 30 JUN 2009
- vitamin E;
- oxidative stress;
- Markov model;
- Monte Carlo simulations
For many years, the prevailing concept was that LDL oxidation plays the central role in atherogenesis. As a consequence, supplementation of antioxidants, particularly vitamin E, became very popular. Unfortunately, major randomized clinical trials yielded disappointing results and recent meta-analyses concluded that indiscriminate, high dose vitamin E supplementation results in increased mortality. This conclusion raised (quite reasonable) criticism, much of which referred to the characteristics of meta-analysis. In our recent study, we used a Markov-model approach, which is free of most of the limitations of meta-analyses. Our major finding was that the average quality-adjusted life years (QALY) of vitamin E- supplemented individuals was 0.30 QALY (95%CI 0.21 to 0.39) less than that of untreated people. In our view, this supports the view that indiscriminate supplementation of high dose vitamin E can not be recommended to the general public.
In the present communication we address several recent studies that demonstrated negative effects of vitamin E and raise possible mechanisms that may be responsible for the harmful effects of vitamin E supplementation. We also review recent studies conducted with specific groups of patients that gained from vitamin E supplementation, indicating that although, on the average, indiscriminate supplementation of high dose vitamin E is not beneficial, specific populations may gain from vitamin E. The challenge is to establish selection criteria that will predict who is likely to benefit from vitamin E supplementation. Such criteria may be based either on the assumption that antioxidants are likely to be beneficial for people under oxidative stress or on knowledge regarding the benefit of sick people with certain diseases. In short, we adopt the view that vitamin E is a “double-edge sword” that should not be consumed until criteria are defined to predict who is likely to benefit from high dose supplementation of vitamin E. © 2009 International Union of Biochemistry and Molecular Biology, Inc.